{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-23-084331","form_type":"8-K","ticker":"TNON","cik":"0001560293","company_name":"Tenon Medical, Inc.","filed_at":"2023-11-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:29.518581+00:00","generated_at":"2026-06-08T15:07:34.148401+00:00","sec_items":["5.03","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Tenon Medical executes 1-for-10 reverse stock split effective Nov 2, 2023 to meet Nasdaq minimum bid","bullets":["Reverse split ratio 1:10; each 10 pre-split shares become 1 post-split share.","Effective 12:01 a.m. ET on Nov 2, 2023; trading on split-adjusted basis under TNON.","Approved by stockholders at Sep 13, 2023 annual meeting; primary goal is to meet $1.00 minimum closing price for Nasdaq listing.","No fractional shares; fractional amounts rounded up to one whole share; new CUSIP 88066N204.","Vstock Transfer acting as exchange agent; stockholders need not take action; book-entry shares handled automatically."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-23-084331","json":"https://secwatch.observer/filing/0001213900-23-084331.json","markdown":"https://secwatch.observer/filing/0001213900-23-084331.md","text":"https://secwatch.observer/filing/0001213900-23-084331.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1560293/000121390023084331/0001213900-23-084331-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1560293/000121390023084331/ea187680-8k_tenonmed.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-08T15:07:34.148401+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"2753a8f4338d194da379516b813ea60aa6e7b636","claim":"Tenon Medical, Inc.: Certificate of Amendment to effect a 1-for-10 reverse stock split (effective 2023-11-02).","evidence_excerpt":"filed on November 1, 2023 a Certificate of Amendment to the Second Amended and Restated Certificate of Incorporation, of the Company with the Secretary of State of the State of Delaware (the “Certificate of Amendment”) that provides for a 1-for-10 reverse stock split (the “Split”) of its shares of common stock, par value $0.001 per share (the “Common Stock”) that became effective at 12:01 a.m. on November 2, 2023.","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1560293/000121390023084331/0001213900-23-084331-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"charter amendment"},{"label":"Effective","value":"2023-11-02"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}